Merck & Co., Ltd.'s Belzutifan submitted a marketing application in China on March 16, 2024.
Previously, the drug has been included in the priority review sequence by the Center for Drug Evaluation (CDE) of the China Medical Products Administration.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: